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Abstract
Background and objective: This systematic review synthesised evidence from European neck and low 
back pain (NLBP) clinical practice guidelines (CPGs) to identify recommended treatment options for use 
across Europe.
Databases and Data Treatment: Comprehensive searches of thirteen databases were conducted, from 1st 
January 2013 to 4th May 2020 to identify up-to-date evidence-based European CPGs for primary care 
management of NLBP, issued by professional bodies/organisations. Data extracted included; aim and 
target population, methods for development and implementation, and treatment recommendations. The 
AGREE II checklist was used to critically appraise guidelines. Criteria were devised to summarise and 
synthesise the direction and strength of recommendations across guidelines.
Results: Seventeen CPGs (11 low back; 5 neck; 1 both) from eight European countries were identified, of 
which seven were high-quality. For neck pain, there was consistent weak or moderate strength 
recommendations for: reassurance, advice and education, manual therapy, referral for exercise 
therapy/programme, oral analgesics and topical medications, plus psychological therapies or 
multidisciplinary treatment for specific subgroups. Notable recommendation differences between back 
and neck pain included, i) analgesics for neck pain (not for back pain); ii) options for back pain specific 
subgroups - work-based interventions, return to work advice/programmes, and surgical interventions (but 
not for neck pain), and iii) a greater strength of recommendations (generally moderate or strong) for back 
pain than those for neck pain. 
Conclusions: This review of European CPGs identified a range of mainly non-pharmacological 
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Significance  
Consensus regarding evidence-based treatment recommendations for patients with neck and low 
back pain (NLBP) from recent European clinical practice guidelines identifies a wide range of 
predominantly non-pharmacological treatment options. This includes options potentially applicable 
to all patients with NLBP and those applicable to only specific patient subgroups. Future work within 
our Back-UP research team will transfer these evidence-based treatment options to an accessible 
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Abstract 
Background and objective: This systematic review synthesised evidence from European neck and 
low back pain (NLBP) clinical practice guidelines (CPGs) to identify recommended treatment options 
for use across Europe. 
Databases and Data Treatment: Comprehensive searches of thirteen databases were conducted, 
from 1st January 2013 to 4th May 2020 to identify up-to-date evidence-based European CPGs for 
primary care management of NLBP, issued by professional bodies/organisations. Data extracted 
included; aim and target population, methods for development and implementation, and treatment 
recommendations. The AGREE II checklist was used to critically appraise guidelines. Criteria were 
devised to summarise and synthesise the direction and strength of recommendations across 
guidelines. 
Results: Seventeen CPGs (11 low back; 5 neck; 1 both) from eight European countries were 
identified, of which seven were high-quality. For neck pain, there was consistent weak or moderate 
strength recommendations for: reassurance, advice and education, manual therapy, referral for 
exercise therapy/programme, oral analgesics and topical medications, plus psychological therapies 
or multidisciplinary treatment for specific subgroups. Notable recommendation differences between 
back and neck pain included, i) analgesics for neck pain (not for back pain); ii) options for back pain 
specific subgroups - work-based interventions, return to work advice/programmes, and surgical 
interventions (but not for neck pain), and iii) a greater strength of recommendations (generally 
moderate or strong) for back pain than those for neck pain.  
Conclusions: This review of European CPGs identified a range of mainly non-pharmacological 
recommended treatment options for NLBP that have broad consensus for use across Europe.  
1. Introduction 
Neck and low back pain (NLBP) are amongst the most frequent reasons for visiting a general 
practitioner (GP) or physiotherapist in primary care in Europe (Bot et al., 2005; Jordan et al., 2010). 
The substantial burden of illness from these conditions was shown by the most recent Lancet-Global 
Burden of Disease study which highlighted low back pain (LBP) as the single highest cause of years 
lived with disability (out of 354 conditions studied), with neck pain ranked eighth (female) and 
twelfth (male) (GBD 2017 Disease and Injury Incidence and Prevalence Collaborators, 2018). 
Outlining potential ways to address this societal burden, the recent Lancet series on LBP (Foster et 
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as current treatment is highly variable (Maserejian et al., 2014) and often not in line with clinical 
guidelines (Darlow et al., 2014; Somerville et al., 2008), leading to suboptimal treatment outcomes 
(Maher et al., 2017). For example, referrals to secondary care specialists are too common, provision 
of self-management advice and education can be limited, opioids and imaging are over-prescribed, 
and sign-posting to locally available non-pharmacological options such as exercise groups is limited 
(Chou et al., 2017a; Koes et al., 2010; Maserejian et al., 2014). Finding solutions that promote best 
practice care for patients with NLBP in first-contact consultations is therefore a priority (Foster et al., 
2012). 
 
Our team is part of Back-UP, a European programme of research developing a digital health 
technology to support clinical decision-making for patients with NLBP based on a stratified care 
approach for first-contact consultations [http://backup-project.eu/]. Decision support tools have 
demonstrated promising results for helping clinicians to translate the most up to date recommended 
evidence into their practice (Murphy et al., 2014). For example, a systematic review of over 160 
randomized controlled trials testing clinical decision-support systems identified improved processes 
of clinical care (e.g. diagnosis, treatment, disease monitoring) or patient outcomes (e.g. clinical 
events, quality of life) in over half of included studies (Roshanov et al., 2013).  
The Keele STarT Back stratified care Tool for back pain has recently been superseded by the Keele 
STarT MSK Tool (Dunn et al., submitted), which has been validated in UK primary care and shown to 
be predictive of pain and disability across a range of common musculoskeletal (MSK) pain sites, 
including NLBP. In addition, a new set of recommended matched treatment options for MSK patients 
at low, medium and high-risk of poor outcome (Babatunde et al., 2017; Protheroe et al., 2019) have 
been piloted in a feasibility trial (Hill et al., accepted). However, these matched treatments were 
designed to evaluate stratified care in UK general practice rather than for use across European 
countries by a broader range of first-contact clinicians such as occupational health physicians. We 
therefore felt the matched treatments should be further refined for the specific context of this 
European project. 
Recent systematic reviews of clinical practice guidelines (CPGs) for musculoskeletal pain (Lin et al., 
2020), and back pain (Wong et al., 2017, Oliveira et al., 2018) aimed to summarize recommended 
treatments for either LBP or neck pain. However, less emphasis was placed on improving decision-
making in first-contact consultations, identifying specific CPG recommendations for patient 
subgroups defined by their risk of persistent pain and disability and the potential relevance, and on 
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recommendations for both neck and low back pain and explored consistencies or similarities 
between recommendations for these common spinal pain presentations. 
The aim of this study was therefore to conduct a systematic review of published European back and 
neck pain clinical guidelines to describe and synthesise the evidence of recommended treatment 
options with broad consensus for use across Europe.  
2. Methods 
A systematic review of contemporary European clinical practice guidelines was conducted and 
reported following the Preferred Reporting Items for Systematic Reviews and Meta-Analyses 
guidance (PRISMA; Moher et al., 2009).  
2.1. Systematic review protocol 
An a priori protocol was written and followed (Available at http://backup-project.eu/?page_id=84).  
2.2. Search strategy 
A comprehensive search strategy was conducted of eight electronic databases (EMBASE, MEDLINE, 
CINAHLPlus, HMIC, PsycINFO, Epistemonikos, Pedro and TRIP database) and four sources of grey 
literature (National Institute for Health and Clinical Excellence (NICE), Scottish Intercollegiate 
Guidelines (SIGN), WHO Guidelines, Guidelines International Network (G-I-N), and DynaMed Plus) 
from 1st January 2013 to 4th May 2020. 
The search strategy utilized both text word searching in the title, abstract or keywords and database 
subject headings, combining terms for neck or back pain and practice guidelines (see Supporting 
information Appendix S1: full search strategy for OVID MEDLINE). For the other databases, search 
terms were adapted to the search capabilities of the platform. 
In addition, our Back UP research partners were asked to identify any relevant guidelines from their 
country. Reference lists of included guidelines were checked to identify additional documents 
relevant to the methodology of the guideline.    
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 Recent evidence-based European clinical guidelines issued by professional bodies or 
organisations for guideline development [published from 2013 onwards]. We included recently 
published guidance only, to ensure treatment recommendations emerging from the review 
would be based on relatively up-to-date evidence; 
 Guidelines concern adult populations (18 years or over), with NLBP (including patients 
presenting to first contact health professionals with symptoms of whiplash related disorders or 
symptoms of radiculopathy such as radicular pain;  
 Guidelines that include recommendations regarding treatment options for patients presenting 
with NLBP, in particular:  
o Treatments deliverable within primary care (as broadly considered across Europe, including 
occupational healthcare) or referral pathways from primary to secondary care 
recommended for clinical practice (in at least two European countries).  
o Treatments aiming to reduce pain, improve function and/or support return to work. 
Relevant outcomes also included evidence-based recommendations regarding factors 
(patient, clinician, environment) that may be associated with effectiveness of treatment, and 
recommendations regarding clinical prediction rules or decision tools supporting the 
selection of treatment for specific patient subgroups (where mentioned in the guideline). 
Exclusion criteria 
 Non-European guidelines; 
 All publications that are not evidence-based clinical practice guidelines, including guidelines 
based solely on consensus or without an explicit literature search, and other publication types: 
systematic reviews, randomised trials, cohort studies, case series, editorials, protocols, letters; 
 Paediatric only populations (under 18 years); 
 NLBP as a result of severe trauma e.g. fracture and spinal cord injury, inflammatory arthritis 
including spondyloarthropathies, and those that focused on broader conditions e.g. (chronic) 
pain that may encompass spinal pain;  
 Guidelines focused on patients managed in secondary care with an established diagnosis of 
radiculopathy; 
 Guidelines focused specifically on surgical treatment options/comparisons or on specific 
interventions not limited to spinal pain e.g. analgesics in older adults; 
 Guidelines that involved populations admitted to hospital (not ambulatory care); 










This article is protected by copyright. All rights reserved 
2.4. Guideline selection 
Results from all searches were imported into EndNote x9 (reference management software, 
Clarivate Analytics. Available at https://endnote.com/) and duplicates removed. Unique citations 
were then imported into Covidence (Veritas Health Innovation, Melbourne, Australia. Available at 
https://www.covidence.org/) to manage the screening process.  
Two reviewers (NC and GM) independently screened all titles and abstracts for relevance against 
eligibility criteria and excluded ineligible publications by agreement. Full texts were independently 
assessed for inclusion by pairs of independent reviewers (NC, GM and DvdW). Disagreements were 
noted and resolved between pairs of reviewers and where necessary the involvement of a third 
reviewer. Reasons for exclusion at the full text stage were recorded.  
2.5. Data extraction 
A data extraction form was purposively designed in Excel to record relevant information from each 
of the clinical practice guidelines included in the review. Complementary documents were sourced 
where relevant, such as methodological reports and evidence syntheses. Information was extracted 
regarding general guideline information (e.g. country, healthcare setting, publication year, target 
population, and presenting symptoms); methods regarding guideline development and 
implementation (e.g. multidisciplinary group/single profession; how strength of evidence 
determined; details regarding consensus methods); and intervention recommendations, specifically 
only those that can be offered in primary care, and guidance for referral (e.g. [strength of] 
recommendations, any details regarding subgroups).  
One reviewer extracted data from each guideline; in the case of guidelines in English this was 
independently checked by a second reviewer with any disagreements resolved through discussion. 
For non-English guidelines no independent check with a second experienced reviewer was feasible 
within the timeline of conducting this review.  
2.6. Assessment of guideline quality 
The AGREE II (Appraisal of Guidelines Research and Evaluation) reporting checklist was used to 
critically appraise guidelines (Brouwers et al., 2010a). Internationally, this is the most widely used 
tool for assessing guideline quality (Siering et al., 2013), with good construct validity and reliability 
(Brouwers et al., 2010b, c). The instrument focuses on guideline development and reporting and 
consists of 23 items addressing 6 domains (1. Scope and purpose; 2. Stakeholder involvement; 3. 
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Each item is rated on a 7-point Likert scale from 1 (Strongly disagree) to 7 (Strongly agree). In 
addition, there are two final items that ask appraisers to give an overall judgement in light of ratings 
given for the 23 items.  
The web-based platform My AGREE PLUS (https://www.agreetrust.org/my-agree/) was used to 
complete appraisals online, based on the user manual. Each item is presented for scoring alongside 
detailed guidance on how to score the item, including where to find relevant information and what 
to consider when deciding on the score for each item. 
Critical appraisal was conducted concurrent to data extraction by the same reviewer(s). One 
reviewer appraised each guideline; in the case of guidelines in English this was independently 
checked by a second reviewer with any disagreements resolved through discussion. For non-English 
guidelines no independent check was feasible. 
No set thresholds exist for determining high/low quality guidelines, however, AGREE II guidance 
suggest users decide these according to their specific context (AGREE Next Steps Consortium, 2017). 
Based on examples given in the AGREE II user manual, and with reference to previous studies 
(Bouwmeester et al., 2009; Lin et al., 2020), we considered guidelines to be of high quality if AGREE 
II Domain 3 i.e. ‘Rigour of development’ scored at least 70%, and the remaining five domains, along 
with the overall assessment, scored at least 50%.  
2.7. Synthesis of guidelines and identification of consistent recommendations 
All recommendations extracted from the included guidelines were collated based on the way the 
treatment option was described in/translated from the guideline, and then grouped according to 
treatment theme. Tables were drawn up to present all the recommendations, alongside details 
regarding the context of the guideline (i.e. professional organisation(s), country, and target 
population/diagnostic classification). Members of the review team, which included researchers with 
academic and clinical expertise in musculoskeletal pain, were presented with these tables for 
review. Following discussion of the many very specific intervention options e.g. different forms of 
exercise, nuanced and/or inconsistently used terms, and translation anomalies/country specific 
terminology (often reported in only 1 or 2 guidelines), interventions were merged by treatment 
type/modality. A general practitioner (physician) was invited to review the recommendations 
relating to medications specifically and undertook a similar process of refining the grouping of 
treatment options. 
The direction (i.e. for, against, or open) and strength of recommendations was harmonised, taking 
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Supporting Information Appendix S2). The resulting nomenclature enables the reader to distinguish 
between strong or weak recommendations based on a formal grading system e.g. GRADE; those 
where no formal grading system was applied; and recommendations based on consensus/expert 
opinion. Treatment or referral options for which a recommendation was formulated in one guideline 
only, were not further considered.  
To summarise and synthesise the direction and strength of recommendations across guidelines a set 
of criteria was devised and followed, such that: 
 Strong FOR/AGAINST recommendation (should do/should not do): consistent 
recommendations in at least two high-quality guidelines from different countries (at least one 
guideline of which reports a 'strong' i.e. // or XX recommendation). 
 Moderate FOR/AGAINST recommendation (could do/could not do): consistent 
recommendations in at least one high-quality (where recommendation is not based on expert 
opinion i.e. O+ or O-) and if only one high-quality, then one or more low quality guidelines.  
 Weak FOR/AGAINST recommendation: recommendations from high quality guidelines but 
based on expert opinion only and/or recommendations from multiple low-quality guidelines. 
 Inconsistent: inconsistent recommendations from guidelines of high quality (for/against). 
 Inconclusive: open/uncertain recommendations only, or recommendations from low quality 
guidelines are inconsistent. 
3. Results 
3.1. Guideline selection 
The systematic search resulted in 3941 unique citations, from which 17 clinical practice guidelines 
(CPGs) were identified (Fig. 1) and included in this evidence synthesis (Bier et al., 2016; Bons et al., 
2017; BÄK et al., 2017; Glocker et al., 2018; Kassolik et al., 2017; Monticone et al., 2013; NICE, 2016; 
Pohl et al., 2018; Regione Toscana, 2015; Schaafstra et al., 2015; SFMT, 2013; Staal et al., 2017; 
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3.2. Guideline characteristics 
An overview of characteristics of included CPGs and the methods used in their development and 
implementation is presented in Table 1, with guideline specific details provided in Supporting 
Information Appendices S3 & S4. The 17 contemporary CPGs originate from 8 European countries 
(Belgium, Denmark, France, Germany, Italy, The Netherlands, Poland, and the UK). The majority 
address low back pain and/or radicular pain (n = 12; 71%), whilst 6 (35%) are concerned with neck 
pain and/or radicular pain. Five guidelines (29%) focus specifically on patients presenting with 
symptoms of radiculopathy. Three of these guidelines (Schaafstra et al., 2015; Sundhedsstyrelsen, 
2015; 2016b) are specifically developed for the management of radiculopathy in general practice or 
primary care. The two other guidelines were designed for healthcare professionals responsible for 
the management of acute lumbar (Glocker et al., 2018) or cervical (Pohl et al., 2018) radiculopathy in 
any ambulant, outpatient or secondary care setting”. Conversely three CPGs (18%) explicitly exclude 
radiculopathy. 
A large majority of CPGs were developed by multidisciplinary groups (n = 14, 82%), employed formal 
grading of evidence and/or recommendations (n = 13, 76%). Just over half the guidelines detailed 
timeframes for future revisions (n = 10, 59%), whilst just under half detailed or undertook a 
consensus process (n = 8, 47%).  
In addition to treatment recommendation most guidelines addressed planning of care (n = 14, 82%), 
diagnostic assessment (n = 12, 71%), evaluation of red (n = 12, 71%) and/or yellow (psychosocial, n = 
10, 59%) flags. Conversely, less than half the guidelines detailed the evaluation of blue/black flags 
i.e. blue: individuals’ perceptions of work-related factors and the relationship between work and 
health, black: system-level factors (context, work environment, policies) (n = 7, 41%), practitioner 
education (n = 8, 47%), or organisation and policy implications (n = 5, 29%). 
 
<<Table 1>> 
3.3. Quality appraisal 
The AGREE II domain scores for each guideline are presented in Table 2, along with our designation 
of the overall quality i.e. high/low based on domain scores. Notably one guideline (Kassolik et al., 
2017) was not rated highly on any of the domains, achieving at its best 44% for clarity of 
presentation. With the exception of this guideline, the remaining 16/17 CPGs were all highly rated 
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(clarity of presentation). Conversely, a minority of CPGs (n = 7, 41%) achieved high ratings for 
Domain 5 (applicability). Domains 2 (stakeholder involvement) and 6 (Editorial independence), 
together with overall assessment score, were each reported to a high quality in a large majority of 
studies (n = 14, 82%). Domain 3 (rigour of development) with its higher cut-off point of 70% 
determining high-quality was achieved by just over half the CPGs (n = 9, 53%). 
Seven CPGs (41%) were considered high quality overall: 2 focused on neck pain, both Danish 
(Sundhedsstyrelsen, 2015, 2016c) and 5 on low back pain including 1 Belgian, 1 UK, 2 Danish, and 1 
German (BÄK et al., 2017; NICE, 2016; Sundhedsstyrelsen, 2016a, b; van Wambeke et al., 2017), 
(Table 2 and Supporting Information Appendices S5 & S6).  
 
<< Table 2 >> 
3.4. Consistency of CPG recommendations for neck pain 
Six guidelines provided treatment recommendations for neck pain (Bier et al., 2016; Kassolik et al., 
2017; Monticone et al., 2013; Pohl et al., 2018; Sundhedsstyrelsen, 2015, 2016c). Supporting 
Information Appendix S5 details the specific treatment options or intervention modalities identified 
in each guideline together with the direction and strength of each recommendation. In total, 
recommendations were provided that covered a wide range of treatment options: reassurance; 
advice and education; medication; injection/infiltration; acupuncture; thermotherapy; manual 
therapy; exercise therapy; postural therapy; traction; electrotherapy; orthotics; ergonomic 
interventions; taping/strapping; psychological interventions; multidisciplinary treatments; referral 
for imaging; and referral for specialist opinion; plus a disparate group of interventions that were 
labelled ‘miscellaneous’.  
In considering the consistency of recommendations across all neck pain CPGs (Table 3), 14 treatment 
options were supported, while recommendations were inconsistent or inconclusive (mixed) 
regarding the use of 7 treatment options. For 26 treatment options a recommendation was only 
given in 1 guideline, and these were not further considered.  
Positive (weak to moderate) recommendations from high quality (Sundhedsstyrelsen, 2015, 2016c) 
or multiple low quality (Bier et al., 2016; Kassolik et al., 2017; Monticone et al., 2013; Pohl et al., 
2018) guidelines supported the use of reassurance; advice and education with specific mention of 
physical activity, and exercise; prescription of oral analgesic medications including for neuropathic 
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exercise interventions alone or in combination with other treatments; and manual therapy in 
combination with another (exercise) intervention.  
Psychological or multimodal (multidisciplinary) interventions were recommended for specific 
subgroups of patients with neck pain, with either psychosocial risk factors or for those with more 
persistent neck pain or disability.  
Recommendations were inconsistent or inconclusive regarding manual therapies (delivered without 
additional active treatment); traction; electrotherapies; thermotherapies; cervical orthoses; 
acupuncture/dry needling; and referral for imaging.  
 
<< Table 3>> 
3.5. Consistency of CPG recommendations for low back pain 
Twelve guidelines provided treatment recommendations for back pain (Bons et al., 2017; BÄK et al., 
2017; Glocker et al., 2018; Kassolik et al., 2017; NICE, 2016; Regione Toscana, 2015; Schaafstra et al., 
2015; SFMT, 2013; Staal et al., 2017; Sundhedsstyrelsen, 2016a, b; van Wambeke et al., 2017). 
Details regarding the specific treatment options or intervention modalities identified from each 
guideline can be found in Supporting Information Appendix S6, along with the direction and strength 
of each recommendation. Similar to guidelines for neck pain, recommendations were provided that 
covered a wide range of treatment and referral options. For many of these treatment options, the 
body of evidence underpinning recommendations was larger compared to neck pain, although often 
still inconsistent or of low quality.  
Table 4 presents the summary of recommendations from high- and low-quality guidelines and the 
overall recommendations derived from our synthesis. A range of treatment options (n=26) were only 
mentioned in one guideline, and these were not considered further. Positive (weak to strong) 
recommendations from high quality (BÄK et al., 2017; NICE, 2016; Sundhedsstyrelsen, 2016a, b; van 
Wambeke et al., 2017) or multiple low quality (Bons et al., 2017; Glocker et al., 2018; Kassolik et al., 
2017; Regione Toscana, 2015; Schaafstra et al., 2015; SFMT, 2013; Staal et al., 2017) guidelines 
supported the use of 14 treatment options, including: reassurance; advice and education with 
specifics for physical activity, exercises, and work; manual therapy in combination with active 
treatment; exercise interventions; group exercise programmes including back schools; psychological 
therapies including cognitive behavioural interventions as standalone interventions or in 
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Psychological therapies are mainly recommended for subgroups of patients with increased 
psychosocial risks, mood problems, or more complex, persistent back pain; while referral for surgery 
is only supported for cases with signs of specific pathology.  
Overall, guidelines recommended strongly against the use of more than a couple of days bedrest for 
patients with low back pain. Referral for imaging is only supported for those with red flags, such as 
increased risk of fracture, infection, (metastatic) cancer, neurological emergencies including cauda 
equina syndrome, aortic aneurysm or systemic inflammatory arthritis (detailed in Supporting 
Information Appendix S7), or deterioration of symptoms. And although mixed, moderate to strong 
recommendations were also given against the use of paracetamol, anti-depressants, 
anticonvulsants, and muscle relaxants; spinal injections for non-specific LBP; traction; orthoses; and 
a range of applications (e.g. electrotherapies, shortwave, laser).  
Recommendations were inconsistent or inconclusive with respect to medication (NSAIDs, opioids; 
topical); epidural steroid and other injections; acupuncture; and manual, postural, and 
thermotherapies. 
<< Table 4>> 
3.6. Comparison of CPG recommendations for neck and low back pain 
In order to examine the consistency of CPG recommendations across neck and low back pain, overall 
strengths of recommendation for each identified intervention (see Tables 3 & 4), were assessed 
(Table 5). Despite a larger body of evidence for the effectiveness of treatment for back pain and a 
larger number of back pain guidelines, recommendations were generally consistent for neck and 
back pain (Table 5), in particular regarding support for the use of advice and education, reassurance, 
certain oral and topical pharmacologic treatments (with the exception of paracetamol), exercise 
interventions, manual therapy when combined with active treatment, and psychological 
interventions. Guidance was also consistent in terms of the limited use of imaging (only for patients 
with red flags or where imaging is likely to change management), and recommendations against the 
use of bed rest, orthoses, traction and a range of modalities (laser therapy, electrotherapy, 
shortwave).  
Referral for imaging or surgical intervention, bed rest, antidepressant and muscle relaxant 
medications, psychological or multidisciplinary interventions are recommended for specific 
subgroups of patients (FOR ‘SPECIFIC SUBGROUP’ or AGAINST ‘WITH EXCEPTIONS’ in Table 5). 
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4. Discussion 
In this review, we have systematically identified, synthesised and graded 17 European clinical 
guidelines relating to the management of NLBP. Based on the quality of the evidence we have 
identified a short list of treatment options recommended for the management of NLBP (see Table 5). 
This information is aimed to provide clinicians, healthcare managers, funders, policymakers and 
researchers with a comprehensive summary of the current consensus from clinical guidelines across 
Europe on the management of NLBP.  
The guidelines included in our review came from 8 European countries (UK, Germany, France, Italy, 
Denmark, Poland, Belgium, and the Netherlands). Eleven of them addressed low back pain, five neck 
pain, and one both LBP and neck pain. Data extraction showed considerable variation in guideline 
development processes with seven guidelines (5 back, 2 neck) considered as high-quality, based on 
their development rigour, strong stakeholder involvement, and the applicability of their 
recommendations. 
For neck pain, high quality guidelines consistently recommended the following evidence-based 
treatment options: reassurance, advice and education (including to remain active and exercise), 
manual therapy in combination with other treatment, referral for exercise therapy/programme, and 
a range of oral analgesics and topical medications, plus psychological therapies or multidisciplinary 
treatment for specific subgroups of patients. There was no strong evidence for use across Europe (as 
shown in Table 3). In contrast to the recommendations for low back pain, the neck pain guidelines 
included the use of painkillers such as paracetamol, NSAIDs (for acute pain only), opioids (for acute 
pain only), and neuropathic pain medication. However, these were only based on weak evidence 
(meaning the recommendations were based on expert opinion only from high quality guidelines, 
and/or multiple low-quality guidelines) and it should be noted that these medications are no longer 
consistently recommended for low back pain within the recent European guidelines. In fact, for low 
back pain the guidelines recommended entirely non-pharmacological treatments, additionally 
including work-based interventions, advice/programmes to return to work, and surgical intervention 
for specific subgroups. These recommendations were based on stronger evidence than those for 
neck pain.  
In relation to previous literature, the findings of this review summarising the consensus from 
European guidelines, are consistent with recommendations in The Lancet back pain series (Foster et 
al., 2018) which advocated for greater use of non-pharmacological options for patients with back 
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recent systematic reviews of clinical practice guidelines for musculoskeletal pain (Lin et al., 2020) 
and back pain (Oliveira et al., 2018) which identified similar key management recommendations 
(patient information, physical activity advice, return to work interventions, exercise interventions), 
although Oliveira et al., additionally identified antidepressants (for chronic LBP), NSAIDs and weak 
opioids for short periods of time (for acute LBP) to be frequently recommended across guidelines.  
Recommendations from the European guidelines included in our review contrast notably with a 
systematic review of non-invasive treatments for low back pain conducted to inform the American 
College of Physicians Clinical Practice Guideline (Chou et al., 2016) which not only recommended 3 
medication options (NSAIDs, opioids, duloxetine) with moderate to strong evidence (Chou et al., 
2017b), but also included acupuncture within a group of 5 recommended non-pharmacological 
options (superficial heat, multi-disciplinary rehabilitation, acupuncture, exercise and manual 
therapy) (Chou et al., 2017a). 
Many of the European guidelines included treatment recommendations related to patient 
subgroups: psychological therapies, multi-disciplinary treatment and referral for surgery were 
recommended for specific subgroups only; and very strict indications (strong recommendation 
against with exception given for bed rest, anti-depressants, and muscle relaxants). However, it was 
notable that clear assessment criteria to facilitate clinician decision-making about when to use these 
treatment options for specific patient subgroups were largely lacking. Similar to Lin et al. who 
highlighted that guidelines for patients with thoracic pain are lacking (Lin et al., 2020), we only 
identified one (low quality) guideline (Kassolik et al., 2017) that specifically addressed thoracic pain. 
We would also highlight that most guidelines lacked detail about the specific dose, duration and 
other detail around the delivery of the recommended treatments. For example, there was little 
clarity on the delivery of physical exercise or the recommended components of patient education or 
reassurance.   
 
Strength and limitations 
The strength of this review is that it provides a helpful overall summary of the treatment and referral 
recommendations from recent European guidelines for NLBP. This overview enabled us to identify 
treatment options that have been consistently recommended across 8 different countries and can 
therefore be considered to have broad European consensus. To facilitate the rigour of this evidence 
summary, we pre-specified inclusion and exclusion criteria for screening, quality appraised 
guidelines using the AGREE II checklist, and devised a set of clear criteria to summarise and 
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included independent assessment of eligibility for inclusion, data extraction and appraisal of the 
quality of guidelines, and a standardised approach to synthesising evidence. 
The guidelines included in our systematic review predominantly originate from northern and 
western European countries (except for the Italian guidelines), which can be considered a limitation. 
This may be partly explained by fewer guidelines being produced in southern or eastern Europe, but 
also by the fact that we only included guidelines published in the past 5 years. Whilst focusing on 
contemporary guidelines (2013 onwards) ensured that we identified the most relevant treatment 
options for current practice, we acknowledge that this meant that some earlier European guidelines, 
were not included. However, for the purposes of this review, we felt it was important to exclude 
guidelines that may not be based on up-to-date evidence of effectiveness. Although we included 
guidelines written in any European language, one limitation was that we were not able to carry out 
independent data extraction and quality appraisal by a second reviewer for guidelines not available 
in English. However, for most of these guidelines, the reviewer had the advantage of being involved 
in data extraction for English language guidelines, which helped to ensure consistency of data 
extraction and interpretation.  
Only 7 CPGs (41%) were considered to be of overall high quality, with limitations mainly related to 
rigour of development (e.g. use of transparent methods to link evidence to recommendations, or 
processes to gain consensus regarding the strength of recommendations); and to applicability with 
few guidelines providing guidance on how to apply recommendations or taking into account 
practical and financial implications of their recommendations. Variation in the methods used to 
grade evidence and agree the strength of recommendations may potentially explain some of the 
variability in treatment recommendations across guidelines. We tried to incorporate quality as well 
as consistency in our synthesis of CPR, aiming to arrive at a transparent and systematic approach for 
summarizing and grading recommendations across guidelines.  
Future work within the Back-UP research project will embed these evidence-based treatment 
options in an accessible clinician decision support tool for first contact clinicians, aiming to offer 
patients with NLBP treatment options better matched to risk of persistent pain and disability.  
5. Conclusion 
In conclusion, this systematic review identified seventeen contemporary clinical guidelines regarding 
NLBP (5 neck; 11 low back; 1 both) from 8 European countries, of which 7 were considered high 
quality. Recommendations were notably consistent for neck and low back pain, despite the larger 
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clinicians have a broad range of mostly non-pharmacological evidence-based treatment options to 
consider for their patients with NLBP. These include some treatments which are a) potentially 
applicable to all patients such as advice and education and b) those applicable only to certain patient 
subgroups (e.g. referral to surgery).  
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Figure 1: PRISMA Flow Diagram. 
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Table 2: Quality appraisal of guidelines: AGREE II domain scores (%) and quality assessment. Cells in 
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Table 3: Consistency of recommendations across guidelines for neck pain (see Supporting 
Information Appendix S5 for individual guidelines). Symbol – classification: // - should do; / - could 
do; /* - for (generic); O [O+/O-] – Open [expert opinion in favour/against]; X* - against (generic); X – 
should not do; XX – definitely do not do (see Supporting Information Appendix S2 for further detail). 
Table 4: Consistency of recommendations across guidelines for low back pain (see Supporting 
Information Appendix S6 for individual guidelines). Symbol – classification: // - should do; / - could 
do; /* - for (generic); O [O+/O-] – Open [expert opinion in favour/against]; X* - against (generic); X – 
should not do; XX – definitely do not do (see Supporting Information Appendix S2 for further detail).  
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Table 1: Characteristics of included clinical practice guidelines. 
Characteristic n Reference 
Country 
Belgium 1 van Wambeke et al., 2017 
Denmark 4 Sundhedsstyrelsen, 2015, 2016a-c 
France 1 SFMT, 2013 
Germany 3 BÄK, et al., 2017; Glocker et al., 2018; Pohl et al., 2018 
Italy 2 Monticone et al., 2013; Regione Toscana, 2015 
The Netherlands 4 Schaafstra et al., 2015; Bier et al., 2016; Bons et al., 2017; Staal et al., 2017 
Poland 1 Kassolik et al., 2017 
UK 1 NICE, 2016 
Pain site 
Neck 5 Monticone et al., 2013; Sundhedsstyrelsen, 2015; Bier et al., 2016; Sundhedsstyrelsen, 2016c; 
Pohl et al., 2018 
Low back 11 SFMT, 2013; Regione Toscana, 2015; Schaafstra et al., 2015; NICE, 2016; Sundhedsstyrelsen, 
2016a-b; BÄK, et al., 2017; Bons et al., 2017; Staal et al., 2017; van Wambeke et al., 2017; Glocker 
et al., 2018 
Neck & low back 1 Kassolik et al., 2017 
Specifically excludes radiculopathy 
Neck 1 Sundhedsstyrelsen, 2016c 
Low back 3  Sundhedsstyrelsen, 2016a; BÄK, et al., 2017; Bons et al., 2017 
Radiculopathy only focus 
Neck 2 Sundhedsstyrelsen, 2015; Pohl et al., 2018 
Low back 3 Schaafstra et al., 2015; Sundhedsstyrelsen, 2016b; Glocker et al., 2018 
Multidisciplinary group or single profession 
Multidisciplinary 14 SFMT, 2013; Regione Toscana, 2015; Schaafstra et al., 2015; Sundhedsstyrelsen, 2015; NICE, 2016; 
Sundhedsstyrelsen, 2016a-c; BÄK, et al., 2017; Bons et al., 2017; Kassolik et al., 2017; van 
Wambeke et al., 2017; Glocker et al., 2018; Pohl et al., 2018 
Single 2 Bier et al., 2016; Staal et al., 2017 
Not reported 1 Monticone et al., 2013 
Formal grading of evidence and/or recommendation 
Yes 13 Monticone et al., 2013; SFMT, 2013; Regione Toscana, 2015; Sundhedsstyrelsen, 2015, Bier et al., 
2016; NICE, 2016; Sundhedsstyrelsen, 2016a-c; BÄK, et al., 2017; Kassolik et al., 2017; Staal et al., 
2017; van Wambeke et al., 2017; Pohl et al., 2018 
No 3 Schaafstra et al., 2015; Bons et al., 2017; Glocker et al., 2018 
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Details of consensus process given   
Yes 8 SFMT, 2013; Schaafstra et al, 2015; NICE, 2016; BÄK, et al., 2017; Bons et al., 2017; Glocker et al., 
2018; Pohl et al. 2018; van Wambeke et al., 2017 
No 9 Monticone et al., 2013; Regione Toscana, 2015; Sundhedsstyrelsen, 2015; Bier et al., 2016; 
Sundhedsstyrelsen, 2016a-c; Kassolik et al., 2017; Staal et al., 2017 
Includes recommendations regarding  
Future revision 10 Sundhedsstyrelsen, 2015; NICE, 2016; Sundhedsstyrelsen, 2016a-c; BÄK, et al., 2017; Staal et al., 
2017; van Wambeke et al., 2017; Glocker et al., 2018; Pohl et al., 2018 
Evaluation of red flags 12 Monticone et al., 2013; SFMT, 2013; Regione Toscana, 2015; Schaafstra et al., 2015; Bier et al., 
2016; NICE, 2016; BÄK, et al., 2017; Staal et al., 2017; van Wambeke et al., 2017; Bons et al., 
2017; Glocker et al., 2018; Pohl et al., 2018 
Evaluation of yellow 
flags 
10 SFMT, 2013; Regione Toscana, 2015; Bier et al., 2016; NICE, 2016; BÄK, et al., 2017; Bons et al., 
2017; Staal et al., 2017; van Wambeke et al., 2017; Pohl et al., 2018; Glocker et al., 2018 
Evaluation of blue/black 
flags 
7 SFMT, 2013; Regione Toscana, 2015; Bier et al., 2016; BÄK, et al., 2017; Bons et al., 2017; Staal et 
al., 2017; van Wambeke et al., 2017 
Diagnosis 12 Monticone et al., 2013; SFMT, 2013; Regione Toscana, 2015; Schaafstra et al., 2015; Bier et al., 
2016; NICE, 2016; BÄK, et al., 2017; Bons et al., 2017; Kassolik et al., 2017; Staal et al., 2017; Pohl 
et al., 2018; Glocker et al., 2018 
Planning of care 14 Monticone et al., 2013; Bier et al., 2016; Pohl et al., 2018; Sundhedsstyrelsen, 2015, 2016a-c; BÄK, 
et al., 2017; Bons et al., 2017; NICE, 2016; Regione Toscana, 2015; Schaafstra et al., 2015; Staal et 
al., 2017; van Wambeke et al., 2017
a
 
Practitioner education 8 Sundhedsstyrelsen, 2015; Regione Toscana, 2015; Sundhedsstyrelsen, 2016a-c; NICE, 2016; van 
Wambeke et al., 2017
a
; Pohl et al., 2018 
















This article is protected by copyright. All rights reserved 

























recommended for use 
Quality 
(high/low) 
Neck pain only          
  Bier et al 2016 72% 94% 52% 67% 38% 50% 67% Yes Low 
  Monticone et al., 2013 50% 33% 38% 100% 0% 50% 33% Yes, with modifications
a 
Low 
  Pohl et al. 2018 61% 72% 54% 89% 17% 92% 50% No Low 
  Sundhedsstyrelsen, 2015 78% 67% 71% 72% 58% 83% 67% Yes, with modifications
a
 High 
  Sundhedsstyrelsen, 2016c 89% 72% 75% 67% 63% 83% 83% Yes High 
Back pain only          
  BÄK et al., 2017 89% 89% 77% 94% 79% 75% 83% Yes High 
  Bons et al., 2017 72% 78% 81% 61% 29% 83% 83% Yes Low 
  Glocker et al., 2018 72% 44% 44% 56% 21% 100% 33% No Low 
  NICE, 2016 100% 78% 79% 94% 79% 58% 83% Yes High 
  Regione Toscana, 2015 83% 78% 48% 100% 25% 17% 50% Yes, with modifications
a
 Low 
  Schaafstra et al. 2015 72% 78% 65% 50% 29% 83% 50% Yes with modifications
a
 Low 
  SFMT, 2013 89% 72% 65% 100% 13% 100% 83% Yes Low 
  Staal B. et al. 2017 83% 83% 77% 94% 33% 42% 67% Yes with modifications
a
 Low 
  Sundhedsstyrelsen, 2016a 78% 67% 71% 61% 63% 83% 67% Yes, with modifications
a
 High 
  Sundhedsstyrelsen, 2016b 89% 72% 79% 72% 63% 83% 83% Yes High 
  van Wambeke et al. 2017 100% 83% 92% 94% 71% 100% 100% Yes High 
Neck and back pain          
  Kasssolik et al. 2017 39% 22% 4% 44% 8% 42% 33% No Low 
a
 AGREE II user manual provides no guidance on what this actually means and so is open to different interpretations by the different reviewers. But, broadly this was taken to mean a 
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Table 3: Consistency of recommendations across guidelines for neck pain (see Appendix S5 for individual guidelines). Symbol – classification: // - should do; / - could do; /* 
- for (generic); O [O+/O-] – Open [expert opinion in favour/against]; X* - against (generic); X – should not do; XX – definitely do not do (see Supporting Information 




Recommendations by guideline quality  
Overall strength of 
recommendation   
Comments 
HIGH quality LOW quality 
FOR 
Reassurance 3(3) 1x O+ 1x /; 1x /* Weak FOR  
Advice and Education 5(5) 1x O+ For: 1x //; 1x /; 1x /* 
Against: 1x X 
Weak FOR  
Remain active (advice) 2(2) 1x O+ 1x / Weak FOR  
Encourage exercise (advice) 3(3) 1x O+ 1x /; 1x /* Weak FOR  
Analgesics incl. for neuropathic pain 2(2)  1x //; 1x /* Weak FOR  
Paracetamol 2(2) 1x O+ 1x / Weak FOR  
NSAIDs 4(3) 2x O+ 1x /; 1x /* Weak FOR Short-term use 
Opioids including tramadol 2(1) 2x O+  Weak FOR Short-term use 
Topical medications incl. NSAIDs 2(2) 1x / 1x /* Moderate FOR  
Manual therapy + other treatment 3(3) 1x / 1x // & /; 1x / & O+ Moderate FOR  
Exercise programs/therapy 5(5) 1x / & O+ 2x //; 1x /; 1x /* Moderate FOR  
Exercise therapy + other treatment 2(2) 1x / 1x // Moderate FOR  
Psychological therapies  3(3)  1x /; 1x /*; 1x O+ Weak FOR SPECIFIC 
SUBGROUPS 
For specific cases: mood problems, psychosocial risks, or 
complex, persistent pain problems 
Multidisciplinary treatment 2(2)  2x / Weak FOR SPECIFIC 
SUBGROUPS 
For those with more complex or persistent pain  
MIXED i.e. inconsistent or inconclusive 
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Against: 1x X* 
Manual therapies  5(4) Mixed: 1x / & O- 
Against: 1x X 
For: 2x //; 1x /* Inconsistent  
Traction 3(3) For: 1x / 
 
Mixed: 1x O+ & X* 
Against: 1x X 
Inconclusive For specific cases: radiculopathy (SST, 2015), Grade III, 
profile D (Bier et al., 2016) 
Electrotherapies 4(4)  Mixed: 1x / & O+ & X; 1 x /* & X* 
Against: 1x XX; 1x X* 
Inconclusive  
Cervical orthoses 4(4)  For: 1x /* 
Mixed: 1x O+ & X* 
Against: 2x O- 
Inconclusive For specific cases: Grade III, profile D (Bier et al.,2016), or 
short-term in cases of severe pain (Pohl et al., 2018) 
Acupuncture/dry needling 4(3) For: 1x / 
Against: 1x O- 
For: 1x // 
Against: 1x X* 
Inconsistent  
Imaging 2(2)  For: 1x // 
Against 1x X* 
Inconclusive  
Single guideline recommendation - in favour of: O+, /*, / or // 
Avoid movement that provokes radiating pain or other 
symptoms in the arm (advice) 
Electrotherapies + active treatment Encourage patient to contact GP, psychologist or psychosomatic 
therapist 
Psychosocial aspects that delay recovery (advice) Kinesiology tape Workplace interventions  
Continue/return to work (advice) Cervical cushion/pillow Referral to GP and/or occupational health officer 
Work-related/occupational advice Bioptron lamps Referral to GP or referring specialist 
Thermotherapy + other treatment Ledotherapy lamps Referral to physical therapist specialized in worker rehabilitation 
Steroids Infra-red lamps Referral to occupational health and safety service 
Spinal epidural steroid injection 
(transforaminal route with imaging) 
Bath salts with mud extracts,  
special water-pearling inserts or ozone  
Referral to occupational health officer or a physical therapist 
specialised in worker rehabilitation  
Postural re-education Magnetic mattress Referral to surgeon/surgery 
Single guideline recommendation - against: O-, X*, X or XX 
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Table 4: Consistency of recommendations across guidelines for low back pain (see Appendix S6 for individual guidelines). Symbol – classification: // - should do; / - could 
do; /* - for (generic); O [O+/O-] – Open [expert opinion in favour/against]; X* - against (generic); X – should not do; XX – definitely do not do (see Supporting Information 




Recommendations by guideline quality  
Overall strength of 
recommendation  
Comments 
HIGH quality LOW quality 
FOR    
Reassurance 4(4) 1x O+ 1x //; 2x /* Weak FOR  
Advice and Education (including 
individualised) 
10(8) 1x //; 1x /; 2x O+ For: 1x //; 4x /*;  
Mixed: 1x O+ & O 
Strong FOR  
Remain active 9(6) 1x // & O+; 2x /; 2x O+ 1x // & O+; 3x /* Strong FOR  
Encourage physical exercise 
(unsupervised) 
7(6) 2x O+ 1x //; 1x // & O+; 3x /* Weak FOR  
Continue/return to work 2(2)  1x // & O+; 1x /* Weak FOR  
Manual therapy in combination with other 
treatment 
4(3) 2x /; 1x O+ 1x /* Moderate FOR  
Exercise programs/therapy 9(6) For: 3x / 
Mixed: 1x // & O 
For: 4x /* 
Against: 1x XX 
Strong FOR  
Group exercise programmes/back schools  3(3) 1x /; 1x / & O+. 1x /* Moderate FOR  
Psychological therapies including 
behavioural and CBT 
4(3) 1x // 3x /* Strong FOR SPECIFIC 
SUBGROUPS 
For specific cases: mood problems, psychosocial 
risks, or complex, persistent pain problems 
Psychological therapies in combination 
with other treatment (exercise) 
2(2) 2x /  Moderate FOR  
Multidisciplinary treatment including MBR 
programs, and multidisciplinary 
rehabilitation involving work focus  
7(5) 1x //; 2x / For: 2x /*; 1x O+ 
Mixed: 1x / & O 
Strong FOR SPECIFIC 
SUBGROUPS 
For specific cases: subacute and chronic LBP with 
patient strongly motivated to resolve and/or 
psychosocial obstacles to recovery. 
Work-based interventions including 
rehabilitation programmes 
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Return to work programmes 3(3) 1x //; 2x O+  Strong FOR  
To surgeon/surgery 8(6) For: 1x //; 1x /; 1x O+ 
Against: 1x XX 
 
For: 2x /*;  
Against: 1x X* 
Mixed: 1x O+ & O 
Strong FOR SPECIFIC 
SUBGROUPS 
For specific cases: failure of non-surgical 
treatment, moderate/severe persistent pain; 
specific indications e.g. cauda equine, severe 
neurological symptoms etc. 
AGAINST    
Bed rest 6(4) 1x XX 1x XX; 4x X* Strong AGAINST WITH 
EXCEPTIONS 
Except: for a few days in severe/acute cases 
Paracetamol 8(6) Against: 3x X, 1x X* For: 1x // & O+ & O; 3x /* 
 
Moderate AGAINST  
Antidepressants including SSRIs, SNRIs, 
Tricyclics 
6(5) Against: 1x X*; 1x XX & X 
Mixed: 1x O+ & X 
 
Against: 1x X* 
Mixed: 1x /* & X* 
Open:  1x O 
Strong AGAINST WITH 
EXCEPTIONS 
For specific cases: comorbid depression (BÄK, et 
al., 2017, high quality) or chronic pain [tricyclics 
only] (Glocker et al., 2018, low quality) 
Anticonvulsants/Antiepileptics including 
gabapentin, pregablin, carbamazepine, 
topiramat 
5(5) Against: 1x XX; 1x X; 1x X* Against: 1x X* 
Mixed: 1x XX & O- & O  
 
Strong AGAINST  
Muscle relaxants including 
diazepines/benzodiazepines 
5(4) Against: 1x XX  
Mixed: 1x XX & X & O+ 
Against: 2x X* 
Mixed: 1x // & O  
 
Strong AGAINST WITH 
EXCEPTIONS 
For specific cases: non-specific LBP where non-drug 
and non-opioid treatments ineffective (BÄK, et al., 
2017, high quality); 2nd line medication for acute 
non-specific LBP (Regione Toscana, 2015, Low 
quality)  
Spinal injections [for non-specific LBP] 6(5) Against: 1x XX; 1x X* 2x X*, 2x O Strong AGAINST  
Traction  6(6) Against: 2x XX; 1x X* For: 1x /* 
Against: 1x O-  
Open: 1x O 
Strong AGAINST  
Electrotherapy including laser therapies, 
TENS, PENS, shortwave diathermy, US, 
ultra-shortwave, inferential, magnetic 
field, electromagnetic, light therapy, 
shockwave, electrostimulation 
6(6) Against: 2x XX; 1x X* Against: 1x O-;  
Mixed: 1x /* & X*; 1x XX & O- & O 
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Orthoses including belts, corsets, foot 
orthotics, insoles, rocker shoes, pull-ups, 
walking stick, elbow crutches and bands 
6(6) Against: 2x XX; 1x X* For: 1x /* 
Against: 1x X 
Mixed: 1x XX & O- & O 
Strong AGAINST  
Imaging 9(6) Against: 3x X 
Mixed: 1x XX & // 
Against: 1x XX; 4x X* Strong AGAINST WITH 
EXCEPTIONS 
Except: in cases of red flags 
MIXED    
NSAIDs 9(7) For: 2x /; 1x / & O+ 
Against: 1x X  
For: 4x /*; 1x // & O 
 
Inconsistent  
Opioids (including tramadol) +/- 
paracetamol (or NSAIDs) 
8(6) Mixed: 1x // & X; 1x O+ & X; 1x / & 
X* 
Against: 1x X 
For: 3x /* 
Mixed: 1x // & O+ & O 
Inconsistent Generally, ‘Against’ for chronic LBP (unless severe 
limitations) and ‘For’ where other analgesics 
ineffective, contraindicated, or not tolerated. 
Topical medications/NSAIDS 3(3) Against: 1 x XX For: 2x /* Inconclusive  
Spinal epidural steroid injection 5(5) For: 1x / 
Mixed: 1x / & X* 
Against: 1x X 
For: 1x /* 
Mixed: 1x O+ & O 
Inconsistent  
Other injections including intravenous, 
intramuscular, infiltration of trigger points 
and ligaments, intradiscal infiltration, 
prolotherapy, Botulium toxin 
2(2) 1x XX 1x O Inconclusive  
Thermotherapy including local heat, 
hot/cold compresses, baths, sauna 
5(4) Mixed: 1x O+ & X 
 
For: 2x /*;  
Open: 1x O 
Mixed: 1x // & O 
Inconsistent  
Manual therapy including mobilisation, 
manipulation and soft-tissue techniques 
8(6) For: 2x / 
Mixed: 1x XX & O 
For: 1x /* 
Against: 2x X* 
Mixed: 1x XX & O; 1x (XX & O- & O) & 
(// & O) 
Inconsistent  
Postural therapies e.g. Alexander therapy, 
postural re-education 
3(3) Open: 2x O  For: 1x /* Inconclusive  
Acupuncture 5(4) For: 1x O+ 
Against: 1x X; 1x X*; 1x O- 
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Open: 1x O  
Single guideline recommendation    
FOR AGAINST 
Analgesics (general) Antibiotics 
Metamizol Flurpirtin 
Collaborate with company doctor, company physical therapist or occupation health and safety service Uridine monophosphate (UMP) 
CAM (general ie acupuncture and TCM, phytotherapy, homeopathy, manual therapies)   Kinesiotaping 
Referral to family doctor   Shock-absorbing or anti-fatigue flooring 
Referral to manual therapist MIXED 
Referral to family doctor, company doctor and/or psychologist    Steroids 
Referral for specialist assessment     Progressive muscle relaxation 
Bioptron lamps (SC)  Phytotherapeutics 
Ledotherapy lamps (SC)    Topical phytotherapeutics 
Infra-red raditation (SC) OPEN 
Bath salts with mud extracts or special water-pearling inserts or even ozone (SC)    Spa treatments 
Magnetic mattress (SC)    Ozone therapy 
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Table 5: Consistency of recommendations across low back pain vs neck pain guidelines 




Overall strength of 
recommendation  
 No. guidelines 
(countries) 
Overall strength of 
recommendation 
Reassurance (advice) 4(4) Weak FOR  3(3) Weak FOR 
Advice and Education (advice) 10(8) Strong FOR  5(5) Weak FOR 
Remain active (advice) 9(6) Strong FOR  2(2) Weak FOR 
Encourage physical exercise (advice) 7(6) Weak FOR  3(3) Weak FOR 
Continue/return to work (advice) 2(2) Weak FOR  1(1) (For) 
Bed rest (advice) 6(4) Strong AGAINST WITH 
EXCEPTIONS 
 1(1) (Against) 
      
Analgesics incl. for neuropathic pain 1(1) (For)  2(2) Weak FOR 
Paracetamol 8(6) Moderate AGAINST  2(2) Weak FOR 
NSAIDs 9(7) Inconsistent  4(3) Weak FOR 
Opioids (including tramadol) +/- paracetamol (or 
NSAIDs) 
8(6) Inconsistent  2(1) Weak FOR 
Antidepressants 6(5) Strong AGAINST WITH 
EXCEPTIONS 
   
Anticonvulsants/Antiepileptics 5(5) Strong AGAINST    
Muscle relaxants 5(4) Strong AGAINST WITH 
EXCEPTIONS 
   
Topical medications incl. NSAIDS 3(3) Inconclusive  2(2) Moderate FOR 
Spinal injections [for non-specific LBP] 6(5) Strong AGAINST    
Spinal epidural steroid injection 5(5) Inconsistent  1(1) (For) 
Other injections  2(2) Inconclusive    
      
Thermotherapy  5(4) Inconsistent  2(2) Inconclusive 
Manual therapy 8(6) Inconsistent  5(4) Inconsistent 
Manual therapy combined with other treatment 4(3) Moderate FOR  3(3) Moderate FOR 
Exercise programs/therapy 9(6) Strong FOR  5(5) Moderate FOR 
Exercise therapy combined with other treatment    2(2) Moderate FOR 
Group exercise programmes/back schools  3(3) Moderate FOR    
Postural therapies  3(3) Inconclusive    
Traction  6(6) Strong AGAINST  3(3) Inconclusive 
Electrotherapy  6(6) Strong AGAINST  4(4) Inconclusive 
Orthoses  6(6) Strong AGAINST  4(4) Inconclusive 
Acupuncture 5(4) Inconsistent  4(3) Inconsistent 
Psychological therapies  4(3) Strong FOR SPECIFIC 
SUBGROUPS 
 3(3) Weak FOR SPECIFIC 
SUBGROUPS 
Psychological therapies combined with other treatment 2(2) Moderate FOR    
Multidisciplinary treatment  7(5) Strong FOR SPECIFIC 
SUBGROUPS 
 2(2) Weak FOR SPECIFIC 
SUBGROUPS 
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Return to work programmes 3(3) Strong FOR    
      
Imaging 9(6) Strong AGAINST WITH 
EXCEPTIONS 
 2(2) Inconclusive 
To surgeon/surgery 8(6) Strong FOR SPECIFIC 
SUBGROUPS 
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through other sources 
(n = 3) 
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(n = 3941) 
Titles and abstracts screened 
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Records excluded 
(n = 3714) 
Full-text articles assessed for 
eligibility 
(n = 227) 
Full-text articles excluded  
(n = 211) 
Reasons: • Not (non-specific) back or neck pain 
focused (n = 39) • Not a full guideline e.g. review, 
editorial, guideline summary (n = 86) • Non-evidence based guideline$ (n = 7) • Non-European guideline$ (n = 24) • Guideline not issued by professional 
body or organisations for guideline 
development including article by same 
team to further disseminate guidance 
(n = 11). • Guideline published before 2013 (n = 1) • Not deliverable within primary care (n 
= 17) • Specific intervention not limited to 
spinal pain (n = 4) • Other reason (n = 22) [guideline in 
development = 3; not a treatment 
guideline = 9; care pathway = 5; 
guideline development process = 1; full 
text unobtainable = 4] 
$ 
including recommendations, consensus 
agreements and care pathways 
 
Unique guidelines in 
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(n = 17) 
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(n = 18) 
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guideline team detailing 
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